Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
12/19/2019
Trade Name:
Conjupri
Generic Name or Proper Name (*):
levamlodipine
Indications Studied:
Hypertension in adults and pediatric patients 6 years and older
Label Changes Summary:
*Indicated in patients 6 to 17 years. *Effect of levamlodipine on blood pressure in patients less than 6 years of age is not known. *Information on dosing, PK parameters, and clinical trials. *New active ingredient.
PREA(P):
P
Sponsor:
CSPC Ouyi Pharmaceutical Co., Ltd.
NNPS:
FALSE
Therapeutic Category:
Antihypertensive
-
-